Targeted Sequencing And Resequencing Market

Targeted Sequencing And Resequencing Market Size, Share, Growth Analysis, By Technology(Sequencing, Re-sequencing, Electrophoresis-based resequencing, NGS), By Application(Clinical application, Plant and animal sciences, Drug development, Others), By Type(DNA-based targeted sequencing, RNA-based targeted sequencing), By End-use(Hospitals & clinics, Academic research, Others), By Regional(North America, Europe, Asia Pacific, Latin America) - Industry Forecast 2025-2032


Report ID: UCMIG35H2153 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Targeted Sequencing And Resequencing Market Insights

Market Overview:

In 2022, the global targeted sequencing and resequencing market reached a significant valuation of USD 5.08 billion. Going forward, this market is projected to witness substantial growth, with a compound annual growth rate (CAGR) of 22.59% anticipated from 2023 to 2030. The escalating adoption of targeted sequencing and resequencing techniques, particularly in the field of genomics research and personalized medicine, is a key driver for this growth. These advanced technologies enable precise analysis of specific regions of DNA, facilitating the identification of genetic variations and aiding in disease diagnosis, treatment selection, and drug development. The continuous advancements in sequencing technologies, coupled with decreasing costs and growing investments in genomics research, are expected to fuel the expansion of the global targeted sequencing and resequencing market in the coming years.

Targeted Sequencing And Resequencing Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Biotechnology by segment aggregation, the contribution of the Biotechnology in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Targeted Sequencing And Resequencing was estimated to be valued at US$ XX Mn in 2021.

The Targeted Sequencing And Resequencing Market is estimated to grow at a CAGR of XX% by 2028.

The Targeted Sequencing And Resequencing Market is segmented on the basis of Technology, Application, Type, End-use, Regional.

Based on region, the Targeted Sequencing And Resequencing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Targeted Sequencing And Resequencing Market are Agilent Technologies, Illumina, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., DNASTAR Inc., PacBio, Bio-Rad Laboratories, Inc., Integrated DNA Technologies, Inc., Perkin Elmer, Inc., RainDance Technologies, Inc., PierianDx, BGI, Genomatix GmbH, Macrogen, Inc., GATC Biotech Ag, Oxford Nanopore Technologies, QIAGEN.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Targeted Sequencing And Resequencing Market

Report ID: UCMIG35H2153

$5,300
BUY NOW GET FREE SAMPLE